8 withdrawn. 8 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Withdrawn 8 |
| Phase 3 | 3 | Withdrawn 3 |
| Phase 1 | 2 | Withdrawn 2 |
Follow PTSD: new trials by email Literature Review of PTSD trials Research Report on PTSD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD Ketamine Hydrochloride - PTSD | Phase 1 / Phase 2 | Withdrawn | University of New Mexico | 2023-12-31 | 2024-03-12 | |
| Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans Midomafetamine, Therapy - PTSD | Phase 2 | Withdrawn | Resilient Pharmaceuticals | 2023-09-01 | 2024-10-30 | |
| Safety and Efficacy Study of TNX-102 SL in Participants With PTSD TNX-102 SL, Placebo - PTSD | Phase 2 | Withdrawn | Tonix Pharmaceuticals, Inc. | 2022-10-14 | 2023-12-11 | |
| Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD CBT + ImRs, CBT + I.E., D-Cycloserine - PTSD | Phase 2 / Phase 3 | Withdrawn | Boston University Charles River Campus | 2016-09-01 | 2023-02-08 | |
| To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD Ketamine, Midazolam - PTSD | Phase 2 / Phase 3 | Withdrawn | Adriana Feder | 2014-12-01 | 2015-03-25 | |
| Mindful Yoga Therapy as an Adjunctive Treatment for PTSD Among OEF/OIF Veterans Mindful Yoga Therapy, Wait-list Control - PTSD | Phase 1 / Phase 2 | Withdrawn | VA Connecticut Healthcare System | 2013-04-01 | 2014-12-19 | |
| Couples-based Behavioral Psychotherapy for Male Patients With Posttraumatic Stress Disorder and Alcohol Dependence Couples-based behavioral psychotherapy - PTSD, Alcohol Dependence | Phase 2 / Phase 3 | Withdrawn | Yale University | 2008-02-01 | 2020-04-02 | |
| Xyrem for Treatment Refractory Insomnia Due to PTSD Xyrem - PTSD, Anxiety, Post Traumatic | Phase 2 | Withdrawn | State University of New York - Upstate Medical University | 2005-08-01 | 2012-09-07 |
Stress Disorders, Post-Traumatic (8) · Alcoholism (1) · Anxiety Disorders (1) · Parasomnias (1)
Mental Disorders (8) · Stress Disorders, Traumatic (8) · Trauma and Stressor Related Disorders (8) · Alcohol-Related Disorders (1) · Chemically-Induced Disorders (1) · Nervous System Diseases (1) · Sleep Wake Disorders (1) · Substance-Related Disorders (1)
Ketamine (2) · Cycloserine (1) · Midazolam (1) · N-Methyl-3,4-methylenedioxyamphetamine (1) · Sodium Oxybate (1) · Therapeutics (1)
Adriana Feder (1) · Boston University Charles River Campus (1) · Resilient Pharmaceuticals (1) · State University of New York - Upstate Medical University (1) · Tonix Pharmaceuticals, Inc. (1) · University of New Mexico (1) · VA Connecticut Healthcare System (1) · Yale University (1)
United States (5) · Kenya (1)
Adriana Feder, MD (1) · Alicia Heapy, Ph.D. (1) · Chris Stauffer, MD (1) · Gregory Sullivan, MD (1) · Ismene L Petrakis, MD (1) · Joseph K Carpenter, M.A. (1) · Megan Pinaire, B.S. (1) · Snehal Bhatt, MD (1) · Thomas L Schwartz, MD (1)